PL368902A1 - Citalopram do leczenia podwyższonego ciśnienia krwi - Google Patents

Citalopram do leczenia podwyższonego ciśnienia krwi

Info

Publication number
PL368902A1
PL368902A1 PL03368902A PL36890203A PL368902A1 PL 368902 A1 PL368902 A1 PL 368902A1 PL 03368902 A PL03368902 A PL 03368902A PL 36890203 A PL36890203 A PL 36890203A PL 368902 A1 PL368902 A1 PL 368902A1
Authority
PL
Poland
Prior art keywords
blood pressure
citalopram
treatment
elevated blood
elevated
Prior art date
Application number
PL03368902A
Other languages
English (en)
Inventor
Pal S. Gabor
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of PL368902A1 publication Critical patent/PL368902A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
PL03368902A 2002-03-14 2003-03-13 Citalopram do leczenia podwyższonego ciśnienia krwi PL368902A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0200980A HU0200980D0 (pl) 2002-03-14 2002-03-14

Publications (1)

Publication Number Publication Date
PL368902A1 true PL368902A1 (pl) 2005-04-04

Family

ID=89980266

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03368902A PL368902A1 (pl) 2002-03-14 2003-03-13 Citalopram do leczenia podwyższonego ciśnienia krwi

Country Status (34)

Country Link
US (1) US7141604B2 (pl)
EP (1) EP1490049B1 (pl)
JP (1) JP2005519945A (pl)
KR (1) KR100718368B1 (pl)
CN (1) CN1259912C (pl)
AT (1) ATE324887T1 (pl)
AU (1) AU2003211195B2 (pl)
BG (1) BG108904A (pl)
BR (1) BR0303384A (pl)
CA (1) CA2459834A1 (pl)
CY (1) CY1106129T1 (pl)
CZ (1) CZ2004661A3 (pl)
DE (1) DE60305018T2 (pl)
DK (1) DK1490049T3 (pl)
EA (1) EA008350B1 (pl)
EE (1) EE200400069A (pl)
ES (2) ES2238939B2 (pl)
HR (1) HRP20040165B1 (pl)
HU (1) HU0200980D0 (pl)
IL (2) IL160486A0 (pl)
IS (1) IS2392B (pl)
LT (1) LT5255B (pl)
LV (1) LV13281B (pl)
MX (1) MXPA04008919A (pl)
NO (1) NO20034998D0 (pl)
PL (1) PL368902A1 (pl)
PT (1) PT1490049E (pl)
SI (1) SI1490049T1 (pl)
SK (1) SK2222004A3 (pl)
TR (1) TR200401036T1 (pl)
UA (1) UA77506C2 (pl)
WO (1) WO2003075914A1 (pl)
YU (1) YU91203A (pl)
ZA (1) ZA200408056B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101137084B1 (ko) * 2003-10-10 2012-04-24 애보트 프러덕츠 게엠베하 셀렉티브 ⅰ1 이미다졸린 수용체 작용제 및 엔지오텐신 ⅱ수용체 차단제를 포함하는 약학적 조성물
DE102004002638A1 (de) * 2004-01-19 2005-08-18 Merck Patent Gmbh Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552012A (en) 1975-12-16 1979-09-05 Du Pont Canada Process for the treatment of comminuted oats
KR100357975B1 (ko) * 1997-07-08 2002-10-25 하. 룬트벡 아크티에 셀스카브 시탈로프램의 제조방법
WO1998019512A2 (en) * 1997-11-11 1998-05-14 H. Lundbeck A/S Method for the preparation of citalopram
US6333357B1 (en) * 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy

Also Published As

Publication number Publication date
HRP20040165A2 (en) 2004-10-31
HU0200980D0 (pl) 2002-05-29
TR200401036T1 (tr) 2005-10-21
SK2222004A3 (en) 2004-08-03
ZA200408056B (en) 2005-10-10
CN1568183A (zh) 2005-01-19
BG108904A (en) 2006-04-28
EA200401147A1 (ru) 2005-02-24
HRP20040165B1 (hr) 2007-08-31
NO20034998D0 (no) 2003-11-10
AU2003211195A2 (en) 2003-09-22
AU2003211195B2 (en) 2007-10-18
US7141604B2 (en) 2006-11-28
LV13281B (en) 2005-09-20
DK1490049T3 (da) 2006-08-21
EP1490049B1 (en) 2006-05-03
EP1490049A1 (en) 2004-12-29
LT2004049A (en) 2005-03-25
ES2263009T3 (es) 2006-12-01
ES2238939A1 (es) 2005-09-01
IS2392B (is) 2008-08-15
HK1075390A1 (en) 2005-12-16
CA2459834A1 (en) 2003-09-18
UA77506C2 (en) 2006-12-15
CZ2004661A3 (cs) 2004-10-13
KR100718368B1 (ko) 2007-05-14
AU2003211195A1 (en) 2003-09-22
LT5255B (lt) 2005-08-25
WO2003075914A1 (en) 2003-09-18
DE60305018D1 (de) 2006-06-08
CY1106129T1 (el) 2011-06-08
EE200400069A (et) 2004-08-16
EA008350B1 (ru) 2007-04-27
MXPA04008919A (es) 2004-11-26
DE60305018T2 (de) 2006-11-30
IL160486A (en) 2008-06-05
KR20040090949A (ko) 2004-10-27
CN1259912C (zh) 2006-06-21
SI1490049T1 (sl) 2006-10-31
ES2238939B2 (es) 2006-04-16
IL160486A0 (en) 2004-07-25
PT1490049E (pt) 2006-08-31
ATE324887T1 (de) 2006-06-15
US20050065209A1 (en) 2005-03-24
BR0303384A (pt) 2004-03-30
JP2005519945A (ja) 2005-07-07
YU91203A (sh) 2006-08-17
IS7418A (is) 2004-08-20

Similar Documents

Publication Publication Date Title
MY127290A (en) New use of flibanserin
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
AU2003297048A1 (en) Cyclohexyl compounds as ccr5 antagonists
WO2004043341A3 (en) Treatment for hemorrhagic shock
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
AU2003296992A1 (en) Pyrrolidine and azetidine compounds as ccr5 antagonists
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
MEP55308A (en) New pharmaceutical compositions containing flibanserin polymorph a
MXPA03010761A (es) Combinaciones farmaceuticas.
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
MXPA04001847A (es) Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad.
IL160486A0 (en) Citalopram for the treatment of elevated blood pressure
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
UA83017C2 (uk) Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
MXPA03010919A (es) Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor.
PL367628A1 (pl) Zastosowanie alkanoilo L-karnityny do sporządzenia leku mającego zastosowanie w leczenia anhedonii
WO2004078761A8 (en) Enantiomerically pure cilazapril,process for preparation
WO2002094377A3 (de) Physiologisch verträgliche kalium- und magnesiumsalze enthaltendes pharmazeutisches präparat und verwendung davon zur therapie von qt-zeitverlängerungen
MXPA03010350A (es) Uso de un gatran para la elaboracion de un medicamento para el tratamiento de fibrosis pulmonar.
TW200519078A (en) 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)